SCHEMBL8619975

SCHEMBL8619975

CCCC(=O)N1CCc2cc(Br)c(OC3CCCN(C)C3)cc21

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.38
KDM1B Q8NB78 1/20 0.38
ROCK1 Q13464 2/20 0.38
PDE4B Q07343 1/20 0.38
TRIM24 O15164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
S1PR1 P21453 2/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
GFER P55789 1/20 0.36
HSD17B10 Q99714 1/20 0.36
XIAP P98170 2/20 0.35
BIRC2 Q13490 2/20 0.35
POLB P06746 1/20 0.35
UTS2R Q9UKP6 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8619530 0.91 TRIM24 (0.41) KDM1AKDM1BROCK1PDE4BTRIM24
SCHEMBL8621841 0.85 HRH3 (0.44) KDM1AKDM1BTRIM24SMN1; SMN2NPC1
SCHEMBL8613836 0.83 KDM1A (0.40) KDM1AKDM1BTRIM24SMN1; SMN2S1PR1
SCHEMBL8617073 0.72 TSHR (0.45) KDM1AKDM1BTRIM24NPC1GAA
SCHEMBL8618434 0.71 HTR1A (0.46)
SCHEMBL8613634 0.69 UTS2R (0.39) MAPTPOLBUTS2R
SCHEMBL8120191 0.68 TRIM24 (0.50) KDM1AKDM1BTRIM24NPC1GAA
SCHEMBL8617695 0.66 NOTUM (0.43) SMN1; SMN2MAPT
SCHEMBL23063855 0.65 CYP11B1 (0.50) SMN1; SMN2MAPTTSHRXIAPBIRC2
SCHEMBL31641521 0.65 HTR2C (0.54) POLBUTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998050346-A2 ACETAMIDE AND UREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 WO disclosed